Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dasatinib | Dasatinib 140 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-051 |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7662 |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7663 |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7664 |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-263 |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-264 |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-265 |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-530 |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-531 |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-532 |
| Erlotinib | Erlotinib 25 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 63304-095 |
| Erlotinib | Erlotinib 100 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 63304-096 |
| Erlotinib | Erlotinib 150 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 63304-135 |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-913 |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-914 |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-915 |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1521 |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1522 |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1523 |
| Erlotiniberlotinib hydrochloride | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Armas Pharmaceuticals Inc. | 72485-217 |
| Erlotiniberlotinib hydrochloride | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Armas Pharmaceuticals Inc. | 72485-218 |
| Erlotiniberlotinib hydrochloride | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Armas Pharmaceuticals Inc. | 72485-219 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-565 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-566 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-567 |